US District Court Rules In Favor Of Neuralstem In Patent Infringement Case Jul 23, 2015 07:45AM
Neuralstem, Inc. Announces Approval for Listing on the NASDAQ Capital Market Jun 29, 2015 09:22AM
Preclinical Data On Neuralstem's Genetically Modified HK532-IGF-1 Stem Cells In Alzheimer's Disease Presented At International Society For Stem Cell Research Annual Meeting Jun 26, 2015 07:32AM
Neuralstem Reports First Quarter 2015 Financial Results And Provides Business and Clinical Update May 8, 2015 07:30AM
Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer May 6, 2015 07:31AM


Mar 16, 2015 07:30AM Neuralstem Reports Fiscal 2014 Fourth Quarter Financial And Year-End Business Results
Mar 12, 2015 06:50AM Neuralstem Announces Topline Results Of Phase II ALS Trial